Skip to main content
. 2021 Sep 17;199(5):507–515. doi: 10.1007/s00408-021-00475-1

Table 4.

Correlation between the scores assigned to the frequency of prescription and to the perceived effectiveness of the different treatments for refractory or unexplained chronic cough. Values are presented as the Spearman rho [ρ] with its square [ρ2]

Family physicians
(n = 620)
Pulmonologists
(n = 92)
Allergists
(n = 62)
All
(n = 774)
ρ (ρ2) ρ (ρ2) ρ (ρ2) ρ (ρ2)
Antitussives(1) 0.640 (0.410) 0.674 (0.454) 0.581 (0.338) 0.644 (0.418)
Opioids(2) 0.545 (0.297) 0.446 (0.217) 0.673 (0.453) 0.563 (0.317)
Mucolytics(3) 0.756 (0.572) 0.683 (0.466) 0.723 (0.523) 0.748 (0.560)
Levodropropizine 0.650 (0.423) 0.699 (0.489) 0.488 (0.238) 0.653 (0.426)
Terpene derivatives 0.493 (0.243) 0.451 (0.203) 0.363 (0.132) 0.478 (0.228)
Antihistamines 0.723 (0.523) 0.625 (0.390) 0.554 (0.307) 0.697 (0.486)
Inhaled corticosteroids 0.684 (0.468) 0.715 (0.511) 0.638 (0.407) 0.670 (0.449)
Oral corticosteroids 0.652 (0.425) 0.561 (0.315) 0.633 (0.401) 0.632 (0.399)
Inhaled bronchodilators 0.728 (0.530) 0.689 (0.475) 0.701 (0.491) 0.708 (0.501)
Neuromodulators(4) 0.663 (0.440) 0.725 (0.526) 0.722 (0.521) 0.694 (0.482)

(1) dextromethorphan, cloperastine; (2) codeine, dimemorfan; (3) guaifenesin, acetylcysteine, ambroxol; (4) gabapentin, pregabalin